Cargando…
Identification of the Binding Sites on Rab5 and p110beta Phosphatidylinositol 3-kinase
Rab5 is a small monomeric GTPase that mediates protein trafficking during endocytosis. Inactivation of Rab5 by GTP hydrolysis causes a conformational change that masks binding sites on its “switch regions” from downstream effectors. The p85 subunit of phosphatidylinositol 3-kinase (PI3K) is a GTPase...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700975/ https://www.ncbi.nlm.nih.gov/pubmed/29170408 http://dx.doi.org/10.1038/s41598-017-16029-6 |
_version_ | 1783281232266657792 |
---|---|
author | Whitecross, Dielle E. Anderson, Deborah H. |
author_facet | Whitecross, Dielle E. Anderson, Deborah H. |
author_sort | Whitecross, Dielle E. |
collection | PubMed |
description | Rab5 is a small monomeric GTPase that mediates protein trafficking during endocytosis. Inactivation of Rab5 by GTP hydrolysis causes a conformational change that masks binding sites on its “switch regions” from downstream effectors. The p85 subunit of phosphatidylinositol 3-kinase (PI3K) is a GTPase activating protein (GAP) towards Rab5. Whereas p85 can bind with both Rab5-GTP and Rab5-GDP, the PI3K catalytic subunit p110β binds only Rab5-GTP, suggesting it interacts with the switch regions. Thus, the GAP functions of the catalytic arginine finger (from p85) and switch region stabilization (from p110β) may be provided by both proteins, acting together. To identify the Rab5 residues involved in binding p110β, residues in the Rab5 switch regions were mutated. A stabilized recombinant p110 protein, where the p85-iSH2 domain was fused to p110 (alpha or beta) was used in binding experiments. Eleven Rab5 mutants, including E80R and H83E, showed reduced p110β binding. The Rab5 binding site on p110β was also resolved through mutation of p110β in its Ras binding domain, and includes residues I234, E238 and Y244. This is a second region within p110β important for Rab5 binding. The Rab5-GTP:p110β interaction may be further elucidated through the characterization of these non-binding mutants in cells. |
format | Online Article Text |
id | pubmed-5700975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-57009752017-11-30 Identification of the Binding Sites on Rab5 and p110beta Phosphatidylinositol 3-kinase Whitecross, Dielle E. Anderson, Deborah H. Sci Rep Article Rab5 is a small monomeric GTPase that mediates protein trafficking during endocytosis. Inactivation of Rab5 by GTP hydrolysis causes a conformational change that masks binding sites on its “switch regions” from downstream effectors. The p85 subunit of phosphatidylinositol 3-kinase (PI3K) is a GTPase activating protein (GAP) towards Rab5. Whereas p85 can bind with both Rab5-GTP and Rab5-GDP, the PI3K catalytic subunit p110β binds only Rab5-GTP, suggesting it interacts with the switch regions. Thus, the GAP functions of the catalytic arginine finger (from p85) and switch region stabilization (from p110β) may be provided by both proteins, acting together. To identify the Rab5 residues involved in binding p110β, residues in the Rab5 switch regions were mutated. A stabilized recombinant p110 protein, where the p85-iSH2 domain was fused to p110 (alpha or beta) was used in binding experiments. Eleven Rab5 mutants, including E80R and H83E, showed reduced p110β binding. The Rab5 binding site on p110β was also resolved through mutation of p110β in its Ras binding domain, and includes residues I234, E238 and Y244. This is a second region within p110β important for Rab5 binding. The Rab5-GTP:p110β interaction may be further elucidated through the characterization of these non-binding mutants in cells. Nature Publishing Group UK 2017-11-23 /pmc/articles/PMC5700975/ /pubmed/29170408 http://dx.doi.org/10.1038/s41598-017-16029-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Whitecross, Dielle E. Anderson, Deborah H. Identification of the Binding Sites on Rab5 and p110beta Phosphatidylinositol 3-kinase |
title | Identification of the Binding Sites on Rab5 and p110beta Phosphatidylinositol 3-kinase |
title_full | Identification of the Binding Sites on Rab5 and p110beta Phosphatidylinositol 3-kinase |
title_fullStr | Identification of the Binding Sites on Rab5 and p110beta Phosphatidylinositol 3-kinase |
title_full_unstemmed | Identification of the Binding Sites on Rab5 and p110beta Phosphatidylinositol 3-kinase |
title_short | Identification of the Binding Sites on Rab5 and p110beta Phosphatidylinositol 3-kinase |
title_sort | identification of the binding sites on rab5 and p110beta phosphatidylinositol 3-kinase |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700975/ https://www.ncbi.nlm.nih.gov/pubmed/29170408 http://dx.doi.org/10.1038/s41598-017-16029-6 |
work_keys_str_mv | AT whitecrossdiellee identificationofthebindingsitesonrab5andp110betaphosphatidylinositol3kinase AT andersondeborahh identificationofthebindingsitesonrab5andp110betaphosphatidylinositol3kinase |